Gray matter is targeted in first-attack multiple sclerosis
about
Proteomic profiling in multiple sclerosis clinical courses reveals potential biomarkers of neurodegenerationNew and emerging immune-targeted drugs for the treatment of multiple sclerosisCSF-PR 2.0: An Interactive Literature Guide to Quantitative Cerebrospinal Fluid Mass Spectrometry Data from Neurodegenerative Disorders.Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.Recent developments in proteomic methods and disease biomarkers.Gray matter-related proteins are associated with childhood-onset multiple sclerosisDetection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis.Kallikrein-related peptidase 6 exacerbates disease in an autoimmune model of multiple sclerosis.Differences in the molecular structure of the blood-brain barrier in the cerebral cortex and white matter: an in silico, in vitro, and ex vivo study.Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.Protease activated receptor 2 controls myelin development, resiliency and repair.Decreased Neuro-Axonal Proteins in CSF at First Attack of Suspected Multiple Sclerosis.The Thrombin Receptor Restricts Subventricular Zone Neural Stem Cell Expansion and Differentiation.
P2860
Q21131975-E230DCF9-FE19-407D-9F67-12CAC3521434Q26997067-9A20722A-48F5-444E-9849-D2905FE6689DQ31144959-BD79215C-514B-4004-81BE-73300D434FA0Q35059951-47DF1FAF-620E-4FC9-9B63-97C02D1DFBB2Q35197167-3B91C694-EC2F-4794-A6D7-9751D44D1A24Q36092695-C9E5776E-20C7-419C-AD48-E2240120A5C8Q37004557-38A2D4D8-98B9-4AD6-84C1-880F90A65284Q40027938-EC788D00-B242-4F5D-8DDB-D8318628E4A1Q45049071-B1EDF4E6-6117-40CD-9685-6767159D6BE5Q45119931-9937FEE3-DFFF-4333-8B51-FFC2C638950DQ47211664-B3971279-C0B6-4FAA-8ABD-A67C6F21A68EQ47663969-A30F9EBF-1B51-49F0-B9BC-D13D8E113F9FQ47755754-106E1E63-F0FF-4DEC-A4F4-690BDDE2FCB3Q55403496-AF62FBBE-AF50-4782-ABB7-72B287B85102
P2860
Gray matter is targeted in first-attack multiple sclerosis
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Gray matter is targeted in first-attack multiple sclerosis
@ast
Gray matter is targeted in first-attack multiple sclerosis
@en
Gray matter is targeted in first-attack multiple sclerosis
@nl
type
label
Gray matter is targeted in first-attack multiple sclerosis
@ast
Gray matter is targeted in first-attack multiple sclerosis
@en
Gray matter is targeted in first-attack multiple sclerosis
@nl
prefLabel
Gray matter is targeted in first-attack multiple sclerosis
@ast
Gray matter is targeted in first-attack multiple sclerosis
@en
Gray matter is targeted in first-attack multiple sclerosis
@nl
P2093
P2860
P50
P1433
P1476
Gray matter is targeted in first-attack multiple sclerosis
@en
P2093
Bart K Holland
David G Camp
Denes Zadori
Patricia K Coyle
Steven E Schutzer
Thomas E Angel
P2860
P304
P356
10.1371/JOURNAL.PONE.0066117
P407
P577
2013-01-01T00:00:00Z